NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinoma

Lancet Oncol. 2011 Mar;12(3):221-2. doi: 10.1016/s1470-2045(11)70042-0.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / pathology
  • Humans
  • Indazoles
  • Kidney Neoplasms / drug therapy*
  • Pyrimidines / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • Antineoplastic Agents
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib